Join us for our first Veterans in Pharma event at the Product Show from 4:00 – 5:00 pm and network with other veterans and professionals in the industry! Attendees will hear from ISPE Board member Tom Struble about this exciting new venture and also from Mike Grice, board member of MVPvets, a Massachusetts-based 501(c)3 not-for-profit endeavor connecting life science companies with veteran talent. Join us in West Red Level Suite 70 (one level above the show floor) as we brainstorm and discuss ideas and goals for the new Veterans in Pharma committee, followed by networking.
Speakers: Thomas Struble is the Director of CQV Operations with DPS Group in Framingham, MA. He has been an active member of ISPE since 2011, serving on the Product Show planning committee since 2013, as chair of that committee from 2016-2018, and currently serving on the Board of Directors as Secretary. He manages a group of Commissioning, Qualification and Validation professionals who deliver capital projects for DPS’s life sciences clients. Prior to DPS he consulted in the biopharma industry for nearly 7 years, and spent over 6 years before that driving nuclear submarines in the US Navy. Tom has a Masters of Engineering Management from Old Dominion University and a BS in Geological Sciences from Cornell, where he met his wife, a successful residential architect. He enjoys traveling, playing with his two daughters, and skiing.
Mike Grice is the Chief Operating Officer of Boost Oxygen, which is the the nation’s premier supplemental oxygen company. As a U.S. Marine, he has commanded combat units in both Iraq and Afghanistan where he was decorated for heroism, leadership, and meritorious service.
After hanging up his uniform, Mike has been very active in the veteran-related non-profit space. He served as the Chief Operating Officer for two nonprofits, MVPVets and PsychArmor, helping both become successful organizations. He is very active with the Boy Scouts of America as an Assistant Scoutmaster and serves on several veteran related nonprofit boards of directors.